Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction
- 28 February 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 24 (2), 166-169
- https://doi.org/10.1016/j.healun.2003.09.043
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantationThe Journal of Heart and Lung Transplantation, 1999
- SAFETY, TOLERABILITY AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL BASED FORMULATION OF CYCLOSPORINE - RESULTS AT SIX MONTHS AFTER TRANSPLANTATION1,2Transplantation, 1999
- REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2Transplantation, 1999
- Selection and Treatment of Candidates for Heart TransplantationCirculation, 1995